Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.32 USD | +3.09% | +0.82% | -11.28% |
Apr. 01 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 26 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
Financials (USD)
Sales 2022 | 557K | Sales 2023 | 184K | Capitalization | 6.21M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -5M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M | Net cash position 2023 | 6.2M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
1 day | +3.09% | ||
1 week | +0.82% | ||
Current month | +2.23% | ||
1 month | -0.28% | ||
3 months | +19.02% | ||
6 months | -12.86% | ||
Current year | -11.28% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 22-08-14 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 23-10-11 |
Brynner Chiam
BRD | Director/Board Member | - | 23-10-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 7.32 | +3.09% | 463 |
24-04-18 | 7.1 | 0.00% | 5,243 |
24-04-17 | 7.1 | -2.17% | 2,565 |
24-04-15 | 7.257 | -0.04% | 2,054 |
24-04-12 | 7.26 | +1.40% | 3,774 |
Delayed Quote Nasdaq, April 19, 2024 at 09:53 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-11.28% | 6.49M | |
+25.59% | 672B | |
+24.14% | 550B | |
-6.45% | 351B | |
+14.91% | 317B | |
+7.05% | 292B | |
+3.00% | 211B | |
+0.20% | 203B | |
-11.08% | 144B | |
-7.82% | 141B |
- Stock Market
- Equities
- TTNP Stock